Bipartisan Healthcare Transparency Measures Gain Momentum in Congress
Congress took a significant step toward advancing several bipartisan healthcare measures that could become part of a larger year-end legislative package. While many healthcare proposals stall amid partisan disagreements, these bills received broad support in key House and Senate committees.
Although the measures address a range of healthcare policy issues, transparency was a common theme. Hospitals, health insurers, ambulatory surgical centers, and other providers would all face new reporting and disclosure requirements intended to give patients, employers and policymakers greater insight into healthcare pricing.
The House Energy and Commerce Committee unanimously approved the Lower Costs, More Transparency Act of 2026, a comprehensive package that builds on existing federal price transparency requirements. Under the legislation, hospitals would continue to provide pricing information in both consumer-friendly and machine-readable formats, while enhanced statutory requirements and enforcement measures would reinforce compliance.
The legislation also expands transparency requirements for insurers, such as enhanced cost-estimator tools for members and additional reporting related to claims, reimbursement and prescription drug spending. It also incorporates provisions from the Improving Seniors' Timely Access to Care Act, which would establish statutory requirements for faster prior authorization decisions in Medicare Advantage.
Meanwhile, the Senate Health, Education, Labor and Pensions (HELP) Committee advanced the Patients Deserve Price Tags Act of 2026, which shares many of the House bill's transparency goals but differs in several areas. The Senate proposal calls for more detailed reporting from both providers and insurers, including information about prior authorization practices, reimbursement methodologies and claims data. The bill also would require providers to furnish more detailed, itemized bills to patients.
Hospital organizations have expressed concern that some provisions could increase administrative burden and duplicate existing reporting requirements. They also have questioned provisions that would replace existing price-estimator tools with broader public reporting requirements, arguing that personalized estimates may be more useful to patients.
Because these bills advanced with overwhelming committee approval, they have potential for inclusion in a larger healthcare package that Congress is expected to consider later this year alongside other expiring healthcare programs and must-pass legislation.
If enacted, many of the proposals would require hospitals, health systems and other healthcare organizations to review existing price transparency, billing and reporting processes to ensure compliance with expanded federal requirements.
